A population pharmacokinetic‐pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis von Mould, Diane R., Davis, Charles B., Minthorn, Elisabeth A., Kwok, Deborah C., Elliott, Michael J., Luggen, Michael E., Totoritis, Mark C.

Volltext

Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys von Hart, Timothy K., Cook, Richard M., Zia-Amirhosseini, Parnian, Minthorn, Elisabeth, Sellers, Teresa S., Maleeff, Beverly E., Eustis, Scot, Schwartz, Lester W., Tsui, Ping, Appelbaum, Edward R., Martin, Elise C., Bugelski, Peter J., Herzyk, Danuta J.

Volltext

The pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog von DAVIES, B. E, MINTHORN, E. A, DENNIS, M. J, ROSING, H, BEIJNEN, J. H

Volltext

Pharmacokinetics and pharmacodynamics of SB‐240563, a humanized monoclonal antibody directed to human interleukin‐5, in mild asthmatics von Zia‐Amirhosseini, P., Walls, C., Patel, B., Cowley, H., Minthorn, E., Hottenstein, C.S.

Volltext

Bison Procurement in the Far West: A 2,100-Year-Old Kill Site on the Columbia Plateau von Chatters, James C., Campbell, Sarah K., Smith, Grant D., Minthorn, Phillip E.

Volltext

Pharmacokinetic and pharmacodynamic modeling of humanized anti–factor IX antibody (SB 249417) in humans von Chow, Fung‐Sing, Benincosa, Lisa J., Sheth, Sunita B., Wilson, Douglas, Davis, Charles B., Minthorn, Elisabeth A., Jusko, William J.

Volltext

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Argatroban in Combination With A GP IIB/IIIA Antagonist in Patients Undergoing Percutaneous Coronary Intervention (PCI) von Cox, D.S., Aluri, J., Minthorn, E., Holdbrook, F., Parchman, L., Fossler, M.

Volltext

IT IS GOOD THAT YOU ARE LISTENING: THE DYNAMICS OF NATIVE AMERICAN CULTURAL RESOURCE MANAGEMENT von Minthorn, Phillip E.

Volltext

Exploring various measures of the area under the curve for the assessment of dose-proportionality and estimation of bioavailability von Brocks, Dion R, Minthorn, Elisabeth A, Davies, Brian E

Volltext

GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition von GILMARTIN, Aidan G, BLEAM, Maureen R, ZAPPACOSTA, Francesca, ANNAN, Roland, SUTTON, David, LAQUERRE, Sylvie G, GROY, Arthur, MOSS, Katherine G, MINTHORN, Elisabeth A, KULKARNI, Swarupa G, ROMINGER, Cynthia M, ERSKINE, Symon, FISHER, Kelly E, JINGSONG YANG

Volltext

Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction von Gilmartin, Aidan G, Faitg, Thomas H, Richter, Mark, Groy, Arthur, Seefeld, Mark A, Darcy, Michael G, Peng, Xin, Federowicz, Kelly, Yang, Jingsong, Zhang, Shu-Yun, Minthorn, Elisabeth, Jaworski, Jon-Paul, Schaber, Michael, Martens, Stan, McNulty, Dean E, Sinnamon, Robert H, Zhang, Hong, Kirkpatrick, Robert B, Nevins, Neysa, Cui, Guanglei, Pietrak, Beth, Diaz, Elsie, Jones, Amber, Brandt, Martin, Schwartz, Benjamin, Heerding, Dirk A, Kumar, Rakesh

Volltext

Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases von Miles, Timothy J., Hennessy, Alan J., Bax, Ben, Brooks, Gerald, Brown, Barry S., Brown, Pamela, Cailleau, Nathalie, Chen, Dongzhao, Dabbs, Steven, Davies, David T., Esken, Joel M., Giordano, Ilaria, Hoover, Jennifer L., Huang, Jianzhong, Jones, Graham E., Kusalakumari Sukmar, Senthill K., Spitzfaden, Claus, Markwell, Roger E., Minthorn, Elisabeth A., Rittenhouse, Steve, Gwynn, Michael N., Pearson, Neil D.

Volltext

Centering indigenous college student voices and perspectives through photovoice and photo-elicitation von Minthorn, Robin S., Marsh, Tyson E.J.

Volltext

Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity von ATKINS, Charity, QI LIU, CHOUDHRY, Anthony E, ALSAID, Hasan, JUCKER, Beat M, AXTEN, Jeffrey M, KUMAR, Rakesh, MINTHORN, Elisabeth, ZHANG, Shu-Yun, FIGUEROA, David J, MOSS, Katherine, STANLEY, Thomas B, SANDERS, Brent, GOETZ, Aaron, GAUL, Nathan

Volltext

Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor... von Heerding, Dirk A, Rhodes, Nelson, Leber, Jack D, Clark, Tammy J, Keenan, Richard M, Lafrance, Louis V, Li, Mei, Safonov, Igor G, Takata, Dennis T, Venslavsky, Joseph W, Yamashita, Dennis S, Choudhry, Anthony E, Copeland, Robert A, Lai, Zhihong, Schaber, Michael D, Tummino, Peter J, Strum, Susan L, Wood, Edgar R, Duckett, Derek R, Eberwein, Derek, Knick, Victoria B, Lansing, Timothy J, McConnell, Randy T, Zhang, ShuYun, Minthorn, Elisabeth A, Concha, Nestor O, Warren, Gregory L, Kumar, Rakesh

Volltext

Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity von RHODES, Nelson, HEERDING, Dirk A, KAHANA, Jason A, GESKE, Robert S, KIEYMENOVA, Elena V, CHOUDHRY, Anthony E, ZHIHONG LAI, LEBER, Jack D, MINTHORN, Elisabeth A, STRUM, Susan L, WOOD, Edgar R, HUANG, Pearl S, DUCKETT, Derek R, COPELAND, Robert A, KUMAR, Rakesh, EBERWEIN, Derek J, KNICK, Victoria B, LANSING, Timothy J, MCCONNELL, Randy T, GILMER, Tona M, ZHANG, Shu-Yun, ROBELL, Kimberly

Volltext

Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases von Miles, Timothy J., Hennessy, Alan J., Bax, Ben, Brooks, Gerald, Brown, Barry S., Brown, Pamela, Cailleau, Nathalie, Chen, Dongzhao, Dabbs, Steven, Davies, David T., Esken, Joel M., Giordano, Ilaria, Hoover, Jennifer L., Jones, Graham E., Kusalakumari Sukmar, Senthill K., Markwell, Roger E., Minthorn, Elisabeth A., Rittenhouse, Steve, Gwynn, Michael N., Pearson, Neil D.

Volltext

Aminofurazans as potent inhibitors of AKT kinase von Rouse, Meagan B., Seefeld, Mark A., Leber, Jack D., McNulty, Kenneth C., Sun, Lihui, Miller, William H., Zhang, ShuYun, Minthorn, Elisabeth A., Concha, Nestor O., Choudhry, Anthony E., Schaber, Michael D., Heerding, Dirk A.

Volltext

Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients with BRAF V600 Mutation-Positive Solid Tumors von Denton, Cathrine L., Minthorn, Elisabeth, Carson, Stanley W., Young, Graeme C., Richards-Peterson, Lauren E., Botbyl, Jeffrey, Han, Chao, Morrison, Royce A., Blackman, Samuel C., Ouellet, Daniele

Volltext

2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazoles von Lin, Hong, Yamashita, Dennis S., Zeng, Jin, Xie, Ren, Verma, Sharad, Luengo, Juan I., Rhodes, Nelson, Zhang, Shuyun, Robell, Kimberly A., Choudhry, Anthony E., Lai, Zhihong, Kumar, Rakesh, Minthorn, Elisabeth A., Brown, Kristin K., Heerding, Dirk A.

Volltext